Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
OVX-033 by Osivax for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
OVX-033 is under clinical development by Osivax and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
Data Insights
OVX-836 by Osivax for Unspecified Influenza Virus Infections: Likelihood of Approval
OVX-836 is under clinical development by Osivax and currently in Phase II for Unspecified Influenza Virus Infections. According to GlobalData,...